After Yusimry's Discount, Future Adalimumab Pricing Unclear at AshTip Solution.

AshTip NewsLetter |Adalimumab, sold under the brand name Humira, enjoyed a long run as one of the world's best-selling medicines. But its 20-year, competition-free period has ended, and despite its best efforts to delay their arrival, drug manufacturer AbbVie now faces increasing competition from

Medscape

After Yusimry's Discount, Future Adalimumab Pricing Unclear

After Yusimry's Discount, Future Adalimumab Pricing Unclear

Adalimumab, sold under the brand name Humira, enjoyed a long run as one of the world's best-selling medicines. But its 20-year, competition-free period has ended, and despite its best efforts to delay their arrival, drug manufacturer AbbVie now faces increasing competition from biosimilars entering the marketplace.